DJIA 16,551.84 -91.17 -0.55%
NASDAQ 4,803.24 -25.09 -0.52%
S&P 500 1,975.78 -13.09 -0.66%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

5 Things MannKind Corporation's Management Team Wants You To Know

Management had a lot of information to share with investors when it reported second quarter earnings. Here are 5 key takeaways.

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes

Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.

Time to Buy Amgen After Newly Approved Drug?

Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled

MannKind: The Stock Where Tomorrow Never Arrives

Trade-Ideas: Sanofi (SNY) Is Today's Pre-Market Mover With Heavy Volume Stock

Why Sanofi Deserves A Second Look

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

What's Behind Sanofi's Afrezza Pediatric Study For MannKind?

See More Articles...